SMS PHARMACEUTICALS
Back to Income Statement
|
SMS PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹783 Cr | ₹709 Cr | ₹522 Cr | ₹520 Cr | ₹563 Cr |
What is the latest Revenue of SMS PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹783 Cr |
| Mar2024 | ₹709 Cr |
| Mar2023 | ₹522 Cr |
| Mar2022 | ₹520 Cr |
| Mar2021 | ₹563 Cr |
How is Revenue of SMS PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹783 Cr | 10.36 | |
| Mar2024 | ₹709 Cr | 35.86 | |
| Mar2023 | ₹522 Cr | 0.42 | |
| Mar2022 | ₹520 Cr | -7.69 | |
| Mar2021 | ₹563 Cr | - | |
Compare Revenue of peers of SMS PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SMS PHARMACEUTICALS | ₹2,960.9 Cr | -0.2% | -7.2% | 54.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
SMS PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SMS PHARMACEUTICALS | -0.2% |
-7.2% |
54.8% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses